Tianjin Tianyao Pharmaceuticals' subsidiary, Beimei Prostaglandin Eye Drops, has obtained a drug registration certificate.
Tianjin Pharmaceutical Industry (600488.SH) announced that its subsidiary, Tianjin Peace Pharmaceutical Co., Ltd., has recently received the "Drug Registration Certificate" issued by the National Drug Administration for BeiMei Prostaglandin Eye Drops.
Tianjin Tianyao Pharmaceuticals (600488.SH) announced that its subsidiary, Jinyao Heping (Tianjin) Pharmaceuticals Co., Ltd., recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for Betamethasone Eye Drops.
It is reported that Betamethasone Eye Drops are used to lower intraocular pressure in patients with open-angle glaucoma and high eye pressure.
Related Articles
Significant increase in investment just before US IPO: Japanese recycling company Seahawk (SEAH.US) increased its offering size by 67% on the eve of its IPO, aiming to raise $31 million.
GalaxyCore Inc. (688728.SH): The company's 50-megapixel image sensor products have now shipped over 100 million units.
Financial report outlook | "Dual Engine" Resonance of AI ASIC and Optical Interconnection May Consolidate Marvell Technology, Inc. (MRVL.US) Strong Gains in Q1 Financial Report.
Significant increase in investment just before US IPO: Japanese recycling company Seahawk (SEAH.US) increased its offering size by 67% on the eve of its IPO, aiming to raise $31 million.
GalaxyCore Inc. (688728.SH): The company's 50-megapixel image sensor products have now shipped over 100 million units.
Financial report outlook | "Dual Engine" Resonance of AI ASIC and Optical Interconnection May Consolidate Marvell Technology, Inc. (MRVL.US) Strong Gains in Q1 Financial Report.
